ASKA Pharmaceutical Holdings (4886) · InitiativeAdvanced
Establishing a Business Based on Minimally Invasive Testing Methods
First written in FY2022. 2 of 5 entries say "Restated". Latest entry: FY2026.
5entries
5years
1from disclosures
How it moved
Same theme, other companies
Commercialization of Minimally Invasive Testing Methods and Expansion of the Testing BusinessA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026AdvancedAnnual report
「非侵襲性ホルモン量測定キットの普及拡大と微量分析技術の活用により検査事業の拡大を進めるとともに、医薬品事業とのシナジーを活かし、新たな収益機会の創出に取り組んでまいります。」
低侵襲な検査法の事業化方針を、非侵襲性ホルモン量測定キットと微量分析技術を用いた検査事業拡大へ具体化している。 - 2026-03-23AdvancedManagement planning
「We will expand the adoption of non-invasive hormone measurement kits and expand into around-the-pill businesses using our proprietary trace mass spectrometry technology.」
The testing business was described as involving wider adoption of non-invasive hormone measurement kits and development using trace mass spectrometry. - FY2024RestatedAnnual report
「We will work to establish a business based on minimally invasive testing methods in the testing business.」
低侵襲な検査法の事業確立をトータルヘルスケアの具体策として再掲している。 - FY2023RestatedAnnual report
「We will work to establish a business based on minimally invasive testing methods in the testing business.」
低侵襲な検査法の事業確立をトータルヘルスケアの具体策として再掲している。 - FY2022First statedAnnual report
「We will work to establish a business based on minimally invasive testing methods in the testing business.」
The commercialization of minimally invasive testing methods is identified as a specific measure for realizing total healthcare.